Skip to main content
    A

    Anavex Life Sciences Corp (AVXL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.82
    -0.12 (-12.42%)

    Market Cap: $86.53M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    59%(23/39)
    Avg Surprise
    +12.88%
    Streak
    1 Q

    Upcoming Estimates

    Reports Nov 23, 2026 (est.)Period ending Sep 30, 2026
    EPS Consensus-$0.11
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports Feb 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.12
    Range-$0.12 - -$0.12
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago-$0.120.0%
    7d ago-$0.120.0%
    Current-$0.12
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-12.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage4.14x
    Current Ratio15.62xQuick Ratio15.62x
    Trading Statistics
    Beta1.25Avg Volume1.19M
    52-Week High$5.3652-Week Low$0.92

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 52.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 22.1, below 30, the oversold line.

    Moving Averages

    SMA 10$1.09
    SMA 20$1.19
    SMA 50$1.71
    SMA 200$2.88
    EMA 10$1.05
    EMA 20$1.20
    EMA 50$1.64
    EMA 200$3.05

    MACD

    Line: -0.21Signal: -0.21Hist: 0.00

    ADX

    ADX: 55.3+DI: 11.7-DI: 45.6

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$1.26

    Bollinger Bands

    Upper Band$1.49
    Lower Band$0.89
    %B Position5084%(Upper)
    Band Width-0.12

    RSI (14-Day)

    Oversold
    22.1

    Momentum Oscillators

    Stoch %K3.4
    Stoch %D5.1
    Williams %R-96.7
    ROC (10d)-28.3%
    Momentum-0.32
    CCI (20d)-211.4
    MFI (14d)25.2

    Volatility Measures

    ATR (14d)$0.11(13.3%)
    StdDev (20d)0.15
    Hist Vol95.3%(High)

    Volume Flow

    VWAP$0.86
    OBV-73.9M
    AD Line-32.5M
    CMF (20d)-0.124

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio2.4x(High)
    VWMA (20d)$1.16

    Pivot Points

    R3$1.07
    R2$1.03
    R1$0.98
    Pivot Point$0.95
    S1$0.90
    S2$0.87
    S3$0.82

    Advanced Oscillators

    TSI-47.61
    Ultimate Osc32.7
    KST-332.41

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about AVXL

    News

    AVXL Valuation

    Anavex Life Sciences (AVXL) trades at 3.9x forward earnings.

    Forward P/E
    3.9x
    P/B
    0.7x
    All AVXL metrics

    AVXL Profitability: Margins, ROIC and FCF

    Anavex Life Sciences (AVXL) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -12.8%
    AVXL financial statements

    Anavex Life Sciences Competitors

    Peers by sector and size for Anavex Life Sciences (AVXL) include Forian, Nkarta and Seer.

    Sector: Healthcare

    AVXL Bull Case vs Bear Case

    Bull case

    • AVXL beat EPS estimates in 75.0% of its last 8 reported quarters.

    AVXL Earnings: Beat Rate and Next Report

    Anavex Life Sciences (AVXL) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Nov 23, 2026.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    27.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    -$0.11
    AVXL earnings history

    AVXL Earnings Date

    AVXL reports Nov 23, 2026. The date is estimated.

    AVXL Earnings Call

    The latest AVXL earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    See insider activity

    Updated Aug 28, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About AVXL

    When does AVXL report earnings?

    Anavex Life Sciences Corp (AVXL) is expected to report earnings on Nov 23, 2026.

    Does AVXL pay dividends?

    Anavex Life Sciences Corp (AVXL) does not currently pay a regular dividend.

    What is AVXL's market cap?

    Anavex Life Sciences Corp (AVXL) has a market capitalization of $86.53M with a current stock price of $0.82.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.